Skip to content

Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea

A Single Arm, Open-Label, Multi-Center, and Comparative Study of the Anne Sleep System Versus Polysomnography to Diagnose Obstructive Sleep Apnea: ANNE Program for the Non-Invasive Evaluation of Apnea in Sleep (APNEAs)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04643782
Enrollment
287
Registered
2020-11-25
Start date
2021-05-11
Completion date
2021-12-27
Last updated
2023-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea of Adult

Brief summary

The main objective of this study is to evaluate the accuracy of the ANNE Sleep system for the diagnosis of obstructive sleep apnea (OSA) in adults

Detailed description

The main object of this study is to evaluate the accuracy of the ANNE Sleep system for the diagnosis of obstructive sleep apnea (OSA) in adults. Our primary hypothesis is that the ANNE Sleep system is non-inferior compared to polysomnography (PSG) for the diagnosis of obstructive sleep apnea

Interventions

ANNE sleep system

Sponsors

Sibel Health Inc.
CollaboratorINDUSTRY
Northwestern University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Patients will use ANNE Sleep system during one night of polysomnography recording in sleep lab.

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. ≥22 years old. 2. Subjects with suspected OSA based on history and physical who qualify for, and have either a PSG or HSAT ordered, as determined by their regular provider. Subjects with self-reported symptoms of OSA based on the STOP-Bang questionnaire indicating affirmative answers to any of the following: snoring, daytime fatigue/sleepiness/tiredness, partners who have observed the subject stopping breathing or choking/gasping during sleep. Persons with a previous diagnosis of OSA are also eligible. 3. Willingness to give written consent and comply with study procedures

Exclusion criteria

1. An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related to this trial or interferes with the clinical trial and data collection 2. Inability to understand instructions 3. Has a skin abnormality that precludes assessment 4. Has a history of dementia 5. Patients with implanted pacemakers or defibrillators 6. Subject is pregnant, nursing or planning a pregnancy over the expected course of the study

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificity of Obstructive Sleep Apnea (OSA) Diagnosis Using ANNE Sleep System Compared to Polysomnography1 nightThe diagnosis of moderate to severe OSA by determining a patient's Apnea-Hypopnea Index (AHI) using the ANNE Sleep system compared to Polysomnography (PSG) over one (1) night worn concurrently. Sensitivity is the number of true positives divided by the sum of the number of true positives and false negatives. Specificity is the number of true negatives divided by the sum of the number of true negatives and false positives.

Countries

United States

Participant flow

Participants by arm

ArmCount
Single Arm Study
After consent, subjects will wear the ANNE sleep system during an attended PSG study for 1 night. ANNE Sleep: ANNE sleep system
225
Total225

Baseline characteristics

CharacteristicSingle Arm Study
Age, Continuous52.7 years
STANDARD_DEVIATION 14
Ethnicity (NIH/OMB)
Hispanic or Latino
19 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
202 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
20 Participants
Race (NIH/OMB)
Black or African American
26 Participants
Race (NIH/OMB)
More than one race
10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
164 Participants
Region of Enrollment
United States
225 Participants
Sex: Female, Male
Female
127 Participants
Sex: Female, Male
Male
98 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 225
other
Total, other adverse events
0 / 225
serious
Total, serious adverse events
0 / 225

Outcome results

Primary

Sensitivity and Specificity of Obstructive Sleep Apnea (OSA) Diagnosis Using ANNE Sleep System Compared to Polysomnography

The diagnosis of moderate to severe OSA by determining a patient's Apnea-Hypopnea Index (AHI) using the ANNE Sleep system compared to Polysomnography (PSG) over one (1) night worn concurrently. Sensitivity is the number of true positives divided by the sum of the number of true positives and false negatives. Specificity is the number of true negatives divided by the sum of the number of true negatives and false positives.

Time frame: 1 night

ArmMeasureGroupValue (MEAN)
Single Arm StudySensitivity and Specificity of Obstructive Sleep Apnea (OSA) Diagnosis Using ANNE Sleep System Compared to PolysomnographySensitivity89.7 percentage of true cases
Single Arm StudySensitivity and Specificity of Obstructive Sleep Apnea (OSA) Diagnosis Using ANNE Sleep System Compared to PolysomnographySpecificity97.5 percentage of true cases

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026